Source: Eur Respir J 2013; 42: 239-251



Rating:

Share or cite this content

Citations should be made in the following way:
Paolo Spagnolo, Leonardo M. Fabbri, Andrew Bush. Long-term macrolide treatment for chronic respiratory disease. Eur Respir J 2013; 42: 239-251

Member's Comments

Ibrahim Elmaghraby - 11.07.2013 11:33
A complete review on very interesting subject.Thank you.

Related content which might interest you: Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease Source: ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021 Year: 2022 Why short-term antibiotic use in AECB may influence long-term outcomes Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Antibiotic treatment and prophylaxis Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 138s Year: 2001 Long-term azithromycin therapy in severe COPD with repeated exacerbations Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Efficacy and safety of various antimicrobial regimens in the treatment of acute exacerbations of chronic bronchitis Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Long-term effects of non-invasive ventilation in chronic respiratory failure due to chronic obstructive lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 280s Year: 2002 Comparative evaluation of fluoroquinolone efficiency in treatment of infectious acute attack of chronic obstructive bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 512s Year: 2004 Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: management Year: 2010 Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Source: Eur Respir J 2002; 19: 966-975 Year: 2002 Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Drug effects in COPD Year: 2009